Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1544 of 6351
-
Mind-Controlled apple vision pro could help paralyzed people speak
Symptom relief Not yet recruitingThe goal of this study is refine the usability of a BCI capable communication platform. The study will take place in the United States area and will enroll up to 10 participants with late stage ALS, traumatic brain injury (TBI) or spinal cord injury (SCI) that have assistive com…
Sponsor: Cognixion • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New pill targets Hard-to-Treat cancers with RAS mutations
Disease control Recruiting nowThis is an open-label, multi-center phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of HRS-2329 in participants with advanced solid tumors harboring RAS mutations or amplifications.
Phase 1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a common pill protect new Moms' hearts after complicated pregnancies?
Disease control Recruiting nowThe hypertensive disorders of pregnancy (preeclampsia and gestational hypertension) are associated with increased long-term maternal risk of developing cardiovascular disease. Recent evidence suggests that activation of the mineralocorticoid receptor promotes ongoing susceptibili…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New device aims to unclog the Heart's drain for stubborn heart failure patients
Disease control By invitation onlyThe purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, specifically invasive measurement of PAWP during standardized exercise.
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New gene therapy trial hopes to fight Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.
Phase 1 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo aims to fight Hard-to-Treat cancers
Disease control Not yet recruitingThis is a Phase 1, open-label, dose-escalation and cohort expansion study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of IMM2510(Anti-PD-L1 and VEGF trap recombinant protein) combine with IMM01(Anti-CD47 Recombinant Protein)…
Phase 1/2 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC
-
AI-Powered home rehab could transform stroke recovery
Symptom relief Recruiting nowThe AISN multicenter randomized controlled trial will assess the effectiveness of a novel artificial intelligence (AI)-based clinical decision-support system integrated into the Rehabilitation Gaming System (RGS) for home-based post-stroke rehabilitation. Approximately 192 partic…
Sponsor: Eodyne Systems SL • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New hope for endometriosis sufferers: drug trial targets pelvic pain
Symptom relief Recruiting nowThe main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).
Phase 2 • Sponsor: Gesynta Pharma AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New daily adaptive radiotherapy aims to spare saliva glands in head and neck cancer patients
Symptom relief Recruiting nowThis is a randomized, single centre, single blinded prospective study comparing the standard of care imaging guided radiation therapy and daily adaptive radiotherapy (ART) for submandibular gland-sparing in head and neck cancer
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could probiotics help restore bowel control after stoma surgery?
Disease control Recruiting nowThis study aims to propose a novel, easy-to-operate intervention strategy that effectively improves defecation function after stoma reversal and to assess its impact on the gut microbiota.The efficacy and safety of antegrade placement of probiotics into the distal deserted intest…
Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a cancer drug tame rare bleeding Disorder's heart complications?
Disease control By invitation onlyHigh cardiac output secondary to hepatic arteriovenous malformations may be isolated or associated with left heart failure with post-capillary pulmonary hypertension. More rarely, precapillary pulmonary hypertension develops, linked to obstructive pulmonary arterial remodeling, r…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New pill offers hope for fingers that turn white and blue in the cold
Symptom relief Recruiting nowRaynaud's phenomenon is a condition where the blood vessels in participants fingers and toes get too narrow when cold or stressed. This makes participants fingers and toes change colors - they might turn white, then blue, and finally red as blood flow returns. It can be painful a…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can community action and cash help end violence against women? malawi trial aims to find out
Prevention Recruiting nowViolence against women is complex and must be addressed at multiple levels, with leadership from women themselves on how to bring about positive change to free women and girls from daily experiences of violence and to promote their rights. It is in this context that the Pamodzi K…
Sponsor: George Washington University • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Fasting two days a week could shrink fatty liver, new study hopes to prove
Disease control Recruiting nowThe recommended treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) currently focuses on lifestyle changes, including dietary adjustments and increased physical activity. Intermittent fasting is a specific dietary approach in which food intake is restri…
Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
A simple nesting technique might soothe newborns during shots
Symptom relief Recruiting nowThis randomized controlled trial aims to evaluate the effect of nesting during the first intramuscular injection on pain, stress level, physiological parameters, settling time, and breastfeeding success in healthy term newborns delivered by cesarean section. A total of 112 newbor…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New collagen scaffold helps rebuild breasts after cancer surgery
Disease control CompletedThis clinical trial evaluates the safety and efficacy of High Purity Type I Collagen scaffold for breast volume restoration following breast-conserving surgery (BCS). The regenerative collagen matrix serves as a biocompatible scaffold promoting tissue ingrowth, neovascularization…
Sponsor: Adichunchanagiri Institute of Medical Sciences, B G Nagara • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can young breast cancer patients still have children? a new study investigates
Knowledge-focused OngoingThis observational study is to learn about the fertility outcomes and decision after breast cancer diagnosis, and the current status of fertility consultation and decision support in young women diagnosed with breast cancer in China.
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Brain zaps aim to unlock better walking for MS patients
Symptom relief Recruiting nowStudy the impact of rTMS on walking ability in people with Multiple Sclerosis (MS) induced spastic paraparesis and moderate walking disability.
Sponsor: Clinique Neuro-Outaouais • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New cell therapy for MS enters human safety testing
Disease control OngoingThis study aims to explore the safety, tolerability, cellular kinetics, and pharmacodynamics of P-CD19CD20-ALLO1 in participants with progressive multiple sclerosis (PMS) and relapsing multiple sclerosis (RMS).
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers? early trial launches
Disease control Recruiting nowA phase 1/2a, open-label, first-in-human study mainly aimed to evaluate the safety and tolerability of BMS-986517 in participants with solid tumors
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC